REFERENCES Seiwerth S, Brcic L, Vuletic LB, et al
Younger patients ask me about these compounds regularly
We did not receive public comments regarding whether the Axoguard HA+ Nerve Protector TM meets the exclusion requirements of 419.66(b)(4)
After consideration of public comments, discussed in an earlier section of this final rule with comment period, we are finalizing with modification our proposals to replace the estimated allowed amount with the median allowed amount and to add the 10th and 90th percentile allowed amounts, including our proposed methodology for calculating the allowed amounts should the calculated percentile fall between two observed allowed amounts, effective January 1, 2026
The meta-analysis of the randomized trials of folate supplementation also supports this conclusion
Its essential to follow a comprehensive treatment plan, including dietary changes and oral supplements, as recommended by our healthcare professionals